These adverse reactions may or may not be caused by the study drugs. A lot of
research is needed to know whether a drug causes an adverse reaction. These
adverse reactions have been, and will continue to be, reviewed together with all of
the available data for durvalumab and tremelimumab.
The websites listed at the end of this summary may have other information about
adverse reactions or other medical problems that happened during this study.
Did any adverse reactions happen during Part 1?
Part 1
(out of 40 participants)
How many participants had adverse
65.0% (26)
reactions?
How many participants had serious
17.5% (7)
adverse reactions?
How many participants stopped
getting study treatment due to adverse 12.5% (5)
reactions?
What serious adverse reactions happened during Part 1?
The only serious adverse reaction during Part 1 that happened in 2 or more
participants was inflammation of the large intestine. This happened in 5% of
participants, which was 2 out of 40 participants.
There were other serious adverse reactions, but each of these happened in only 1
participant. No participants died due to serious adverse reactions during Part 1.
What adverse reactions happened during Part 1?
The most common adverse reaction during Part 1 was fatigue.
The table below shows the adverse reactions that happened in 2 or more
participants during Part 1. There were other adverse reactions, but each of these
11 | Clinical Study Results